Chronic daily headaches in children.

Chronic daily headaches in children.
复制标题

DOI:
10.1007/s11916-006-0062-7
复制
发表时间:
2006-10-01
影响因子:
3.7
通讯作者:
Powers, Scott W
Powers, Scott W
中科院分区:
医学3区
文献类型:
--
作者:
Hershey, Andrew D;Kabbouche, Marielle A;Powers, Scott W

文献摘要

被引文献

相似文献

慢性日常型头痛(CDH)在儿科和三级儿科头痛治疗中日益受到重视。据估计,多达4%的成年人口患有CDH。其中许多是慢性偏头痛(CM)。患有CDH的儿童人口比例似乎较低,尽管患病率尚未得到充分确定。CDH最简单的定义是每月头痛15天以上。在国际头痛疾病分类第二版(ICHD-II)中,已经确定了几种类型的CDH。这些标准与西尔伯斯坦-利普顿标准进行了对比,并建议进行修订。CDH的诊断更加复杂,可能是由过度使用止痛药(药物过度头痛)引发的,需要在确定最终诊断之前解决这个问题。在儿童中,大多数CDH似乎具有偏头痛特征,尽管它可能不完全符合ICHD-II偏头痛或CM的标准。CDH的评估需要包括完整的病史和体格检查,以确定任何可能的继发性头痛或直接归因于继发性原因的头痛。治疗和管理涉及多学科方法,包括在头痛严重程度增加时进行急性治疗(同时避免过度使用药物),预防治疗以减少CDH的频率和影响,以及生物行为治疗以帮助获得长期结果。
Chronic daily headache (CDH) is increasingly recognized as a problem in pediatrics and tertiary pediatric headache care. It is estimated that up to 4% of the adult population has CDH. Many of these are chronic migraine (CM). The fraction of the pediatric population with CDH appears to be lower, although the prevalence has not been adequately determined. The simplest definition of CDH is more than 15 headache days per month. In the International Classification of Headache Disorders, Second Edition (ICHD-II), several types of CDH have been identified. These criteria have been contrasted with the Silberstein-Lipton criteria, with revisions suggested. The diagnosis of CDH is further complicated and may be initiated by the overuse of analgesic medications (medication overuse headache) and requires the resolution of this issue before a final diagnosis can be established. In children, most CDH appears to have migraine features, although it may not completely meet the ICHD-II criteria for migraine or CM. Evaluation of CDH needs to include a complete history and physical examination to identify any possibility of the secondary headaches or headaches directly attributed to a secondary cause. Treatment and management involve a multidisciplinary approach, including acute therapy for when the headache severity increases (while avoiding medication overuse), preventative therapy to reduce the frequency and impact of the CDH, and biobehavioral therapy to assist with long-term outcome.